RT @NatRevClinOncol: Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated #breastcancer reveals a systemic shift in gen…
RT @NatRevClinOncol: Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated #breastcancer reveals a systemic shift in gen…
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated #breastcancer reveals a systemic shift in genomic aberrations: https://t.co/TlcSYOY9UP #BCSM
RT @GenomeMedicine: New: Time series analysis of #genomic aberrations in a phase II trial of targeted and neoadjuvant chemotherapy for #bre…
New: Time series analysis of #genomic aberrations in a phase II trial of targeted and neoadjuvant chemotherapy for #breastcancer https://t.co/l2Cc0uAyKt https://t.co/SaqD7yONek
RT @GenomeMedicine: Time series analysis of #neoadjuvant #chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift i…
Time series analysis of #neoadjuvant #chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in #genomic aberrations https://t.co/l2Cc0uAyKt https://t.co/lzWHZmYXa7